Glunim P 1mg/500mg/15mg Tablet SR
Marketer
Blair Remedies Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glunim P 1mg/500mg/15mg Tablet SR
GlucoTrim SR tablets (1mg/500mg/15mg) combine medications to manage blood glucose in adults with type 2 diabetes. This therapy complements diet and exercise to enhance blood sugar regulation by improving insulin effectiveness. Always follow your physician's prescribed dosage and frequency. Take with food to prevent stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, omit the missed dose. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before starting GlucoTrim SR, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or breastfeeding individuals must consult their physician. Kidney function tests will be performed prior to treatment initiation. Limit alcohol consumption to minimize potential side effects.
Primary Ingredients of Glunim P 1mg/500mg/15mg Tablet SR
No text provided. Please provide the text you would like me to rephrase.
Uses of Glunim P 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glunim P 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glunim P 1mg/500mg/15mg Tablet SR whole; do not chew, crush, or divide it. Administer this medication with food.
Common Side effects of Glunim P 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glunim P 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glunim P 1mg/500mg/15mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.
How Glunim P 1mg/500mg/15mg Tablet SR works:
Glunim P SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to achieve superior blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glunim P 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glunim P 1mg/500mg/15mg tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glunim P 1mg/500mg/15mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glunim P 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Glunim P 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glunim P 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Glunim P 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glunim P 1mg/500mg/15mg Tablet SR :
Should you forget to take your Glunim P 1mg/500mg/15mg SR tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glunim P 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently